1.	Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: INTERTECC, R21CA162718-01, NCT01554397
2.	Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000654709, RTOG-0724, NCT00980954
3.	Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery Phase: Phase III Type: Tissue collection/Repository, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000670125, GOG-0263, NCT01101451
4.	Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2010-0952, NCT01365156
5.	Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000706698, ANZGOG-0902-GOG-0274/RTOG-1174, ANZGOG-0902-GOG-0274, NCT01414608
6.	Oral Versus Transdermal Ondansetron for Women With Cervical Cancer Receiving Chemoradiation Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2011-1107, NCT01536392
7.	Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000738944, RTOG-1203, NCT01672892
8.	Weekly IV Topotecan and Cisplatin With Radiation in Cervical Carcinoma Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UCI 03-33, NCT00257816
9.	Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: IRB-HSR#13748, CA225243, HRPO #05-0702, NCT00292955
10.	Copper Cu 64-ATSM and PET/CT Scan in Predicting Disease Progression in Patients With Newly-Diagnosed Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Undergoing Chemoradiotherapy Per NCCN Guidelines Phase: Phase II Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000624407, ACRIN-6682, NCT00794339
11.	Image-Guided Gynecologic Brachytherapy Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11-098, NCT01399658
12.	Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2013-00804, CASE 4812, U01CA062502, NCT01835171
13.	Pelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Cervical Cancer Patients Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 05-0977 / 201104019, NCT00359866
14.	Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000695304, GOG-9926, NCT01295502
15.	Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers Phase: Phase I Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MCC-13419, NCI-2011-0098, NCT01375699
16.	Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer Phase: Phase I Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: EPROST-20100153, NCT01485731
17.	Intensity Modulated Radiation Therapy With Cisplatin and Gemcitabine to Treat Locally Advanced Cervical Carcinoma Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UCSD 100597, NCT01554410
18.	Chemoradiation Therapy and Ipilimumab in Treating Patients With Locally Advanced Cervical Cancer Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2012-01733, GOG-9929, U10CA027469, NCT01711515
19.	Chemoradiation-Induced Nausea and Emesis: Quality of Life Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2003-0529, NCT00394602
20.	Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition Phase: No phase specified Type: Health services research, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: HM10390, P01CA116602, NCT00571415
21.	Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer Phase: No phase specified Type: Supportive care, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000646813, GOG-0244, NCT00956670